Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Drew Spaventa
AddedMar 31, 2024
UpdatedMay 31, 2026
Drew Spaventa

Drew Spaventa

Co-Founder, Axon Ventures

CrunchbaseLinkedIn

Drew Spaventa's Career

Axon Ventures
Axon Ventures

Mumbai, Maharashtra, IN

Co-Founder
Singular Genomics
Singular Genomics

San Diego, CA, US

Board Member· Board
Aspen Neuroscience
Aspen Neuroscience

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Drew Spaventa's Career

Axon Ventures
Axon Ventures
71982Mumbai, Maharashtra, IN
Co-Founder

Leadership at Axon Ventures

Afif KhouryAfif KhouryCo-Founder
Singular Genomics
Singular Genomics
Public$176M1342016San Diego, CA, US
Board Member· Board

Leadership at Singular Genomics

Eli GlezerEli GlezerBoard Member
David L. BarkerDavid L. BarkerBoard Member

Similar to Singular Genomics

10x Genomics10x GenomicsPleasanton, CA, USGene Sequencingest. 201210x GenomicsPleasanton, CA, US · est. 2012

10x Genomics: A leading American biotech firm, innovating in gene sequencing since 2012.

Public · $242.6M448
Spatial GenomicsSpatial GenomicsPasadena, CA, USGenomic Analysisest. 2016Spatial GenomicsPasadena, CA, US · est. 2016

Pioneering spatial analysis and comprehensive single-cell assay in intact cells and tissues.

Series A · $56M24
BioSkryb GenomicsBioSkryb GenomicsDurham, NC, USGenomic Toolsest. 2018BioSkryb GenomicsDurham, NC, US · est. 2018

BioSkryb Genomics: Transforming single cell discovery with advanced genomic tools for disease management.

Series A · $31.5M83
Pacific Biosciences of CaliforniaPacific Biosciences of CaliforniaMenlo Park, CA, USGenetic Analysis, Sequencing Systemsest. 2004Pacific Biosciences of CaliforniaMenlo Park, CA, US · est. 2004

Pacific Biosciences, a CA-based medical firm, designs and manufactures sequencing systems for complex genetic analysis.

Public · $2B769
Aspen Neuroscience
Aspen Neuroscience
Series D$264M1122018San Diego, CA, US
Board Member· Board

Leadership at Aspen Neuroscience

Doug FisherDoug FisherBoard Member
Caryn PetersonCaryn PetersonBoard Member
Jeanne LoringJeanne LoringCo-Founder
Peter ThompsonPeter ThompsonBoard Member
Faheem HasnainFaheem HasnainBoard Member
Andrés Bratt-LealAndrés Bratt-LealCo-Founder

Similar to Aspen Neuroscience

ConvalesceConvalesceSan Francisco, CA, USStem Cell Therapyest. 2018ConvalesceSan Francisco, CA, US · est. 2018

Convalesce: Pioneering stem cell therapies for neurodegenerative conditions using advanced biomaterials.

Angel · $250k3
APstem TherapeuticsAPstem TherapeuticsFremont, CA, USStem Cell Therapiesest. 2017APstem TherapeuticsFremont, CA, US · est. 2017

APstem Therapeutics: Advancing stem cell discoveries to combat diseases and aging challenges.

Seed · $4.3M6
NeuronascentNeuronascentClarksville, MD, USTherapeuticsest. 2004NeuronascentClarksville, MD, US · est. 2004

US-based Neuronascent develops pioneering therapeutics for neurodegenerative diseases and depression.

Pre-Seed · $1.3M5
Personalized Stem CellsPersonalized Stem CellsPoway, CA, USStem Cell Servicesest. 2018Personalized Stem CellsPoway, CA, US · est. 2018

Personalized Stem Cells offers FDA-approved, adipose-derived stem cell services for clinical trials.

Seed · $2.4M2

Drew Spaventa's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Drew Spaventa

Nikki SerraNikki SerraCEO · Singular VenturesSteve WarneckeSteve WarneckeBoard Member · Rockies Venture ClubWilliam HagstromWilliam HagstromCo-Founder · Biolytx PharmaceuticalsGreg CritchfieldGreg CritchfieldBoard Member · Sera PrognosticsKrishna jayaramanKrishna jayaramanBoard Member · Genomics USAAlice ZhangAlice ZhangFounder & CEO · Verge Genomics